JP2011509956A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011509956A5 JP2011509956A5 JP2010542534A JP2010542534A JP2011509956A5 JP 2011509956 A5 JP2011509956 A5 JP 2011509956A5 JP 2010542534 A JP2010542534 A JP 2010542534A JP 2010542534 A JP2010542534 A JP 2010542534A JP 2011509956 A5 JP2011509956 A5 JP 2011509956A5
- Authority
- JP
- Japan
- Prior art keywords
- imiquimod
- composition
- treatment
- administered
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 9
- DOUYETYNHWVLEO-UHFFFAOYSA-N imiquimod Chemical compound C1=CC=CC2=C3N(CC(C)C)C=NC3=C(N)N=C21 DOUYETYNHWVLEO-UHFFFAOYSA-N 0.000 claims 7
- 229960002751 imiquimod Drugs 0.000 claims 7
- 208000015634 Rectal Neoplasms Diseases 0.000 claims 2
- 238000009098 adjuvant therapy Methods 0.000 claims 2
- 210000001072 colon Anatomy 0.000 claims 2
- 208000022131 polyp of large intestine Diseases 0.000 claims 2
- 208000015768 polyposis Diseases 0.000 claims 2
- 206010038038 rectal cancer Diseases 0.000 claims 2
- 201000001275 rectum cancer Diseases 0.000 claims 2
- 206010009944 Colon cancer Diseases 0.000 claims 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims 1
- 206010061598 Immunodeficiency Diseases 0.000 claims 1
- 201000010989 colorectal carcinoma Diseases 0.000 claims 1
- 239000006071 cream Substances 0.000 claims 1
- 239000006260 foam Substances 0.000 claims 1
- 210000004877 mucosa Anatomy 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US645908P | 2008-01-15 | 2008-01-15 | |
| PCT/EP2008/011088 WO2009089900A1 (en) | 2008-01-15 | 2008-12-23 | Treatment of colon diseases or prevention of colorectal carcinoma with imidazoquinoline derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2011509956A JP2011509956A (ja) | 2011-03-31 |
| JP2011509956A5 true JP2011509956A5 (https=) | 2013-12-12 |
Family
ID=40419193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010542534A Pending JP2011509956A (ja) | 2008-01-15 | 2008-12-23 | イミダゾリキノリン誘導体を用いた大腸疾病の治療又は結腸直腸癌腫の予防 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8008319B2 (https=) |
| EP (1) | EP2237780A1 (https=) |
| JP (1) | JP2011509956A (https=) |
| CN (1) | CN101909624A (https=) |
| AU (1) | AU2008347400B2 (https=) |
| BR (1) | BRPI0822002A2 (https=) |
| CA (1) | CA2708559C (https=) |
| EA (1) | EA018579B1 (https=) |
| GE (1) | GEP20125605B (https=) |
| IL (1) | IL205819A (https=) |
| MX (1) | MX2010007699A (https=) |
| NZ (1) | NZ586161A (https=) |
| UA (1) | UA101339C2 (https=) |
| WO (1) | WO2009089900A1 (https=) |
| ZA (1) | ZA201003906B (https=) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5694345B2 (ja) | 2009-10-22 | 2015-04-01 | ギリアード サイエンシーズ， インコーポレイテッド | Ｔｏｌｌ様受容体の調節因子 |
| CN112587671A (zh) | 2012-07-18 | 2021-04-02 | 博笛生物科技有限公司 | 癌症的靶向免疫治疗 |
| DK3092256T3 (da) | 2014-01-10 | 2022-06-20 | Birdie Biopharmaceuticals Inc | Forbindelser og sammensætninger til immunterapi |
| CN121243402A (zh) | 2014-07-09 | 2026-01-02 | 博笛生物科技有限公司 | 用于治疗肿瘤的抗-pd-l1组合 |
| CN112587672A (zh) | 2014-09-01 | 2021-04-02 | 博笛生物科技有限公司 | 用于治疗肿瘤的抗-pd-l1结合物 |
| CN106943597A (zh) | 2016-01-07 | 2017-07-14 | 博笛生物科技（北京）有限公司 | 用于治疗肿瘤的抗-egfr组合 |
| CN115350279A (zh) | 2016-01-07 | 2022-11-18 | 博笛生物科技有限公司 | 用于治疗肿瘤的抗-her2组合 |
| CN106943596A (zh) | 2016-01-07 | 2017-07-14 | 博笛生物科技（北京）有限公司 | 用于治疗肿瘤的抗-cd20组合 |
| CN108794467A (zh) | 2017-04-27 | 2018-11-13 | 博笛生物科技有限公司 | 2-氨基-喹啉衍生物 |
| CA3067268A1 (en) * | 2017-06-23 | 2018-12-27 | Birdie Biopharmaceuticals, Inc. | Crystalline resiquimod monosulfate anhydrate and its preparation and uses |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2078547C1 (ru) * | 1995-11-28 | 1997-05-10 | Центральный научно-исследовательский рентгено-радиологический институт МЗМП РФ | Способ лечения полипоза желудка и двенадцатиперстной кишки |
| UA74852C2 (en) * | 2000-12-08 | 2006-02-15 | 3M Innovative Properties Co | Urea-substituted imidazoquinoline ethers |
| WO2002053138A2 (en) * | 2001-01-02 | 2002-07-11 | Elisabeth Shanahan-Prendergast | Treatment for inhibiting neoplastic lesions using incensole and/or furanogermacrens |
| US20060193789A1 (en) * | 2002-10-25 | 2006-08-31 | Foamix Ltd. | Film forming foamable composition |
| PT1687305E (pt) * | 2003-11-21 | 2008-10-17 | Novartis Ag | Derivados de 1h-imidazoquinolina como inibidores de proteína quinase |
-
2008
- 2008-12-23 AU AU2008347400A patent/AU2008347400B2/en not_active Ceased
- 2008-12-23 WO PCT/EP2008/011088 patent/WO2009089900A1/en not_active Ceased
- 2008-12-23 BR BRPI0822002A patent/BRPI0822002A2/pt not_active IP Right Cessation
- 2008-12-23 NZ NZ586161A patent/NZ586161A/en unknown
- 2008-12-23 CN CN2008801223531A patent/CN101909624A/zh active Pending
- 2008-12-23 MX MX2010007699A patent/MX2010007699A/es active IP Right Grant
- 2008-12-23 UA UAA201006372A patent/UA101339C2/ru unknown
- 2008-12-23 CA CA2708559A patent/CA2708559C/en not_active Expired - Fee Related
- 2008-12-23 JP JP2010542534A patent/JP2011509956A/ja active Pending
- 2008-12-23 GE GEAP200811913A patent/GEP20125605B/en unknown
- 2008-12-23 EP EP08871156A patent/EP2237780A1/en not_active Withdrawn
- 2008-12-23 EA EA201001164A patent/EA018579B1/ru not_active IP Right Cessation
-
2009
- 2009-01-14 US US12/353,683 patent/US8008319B2/en not_active Expired - Fee Related
-
2010
- 2010-05-17 IL IL205819A patent/IL205819A/en not_active IP Right Cessation
- 2010-06-01 ZA ZA2010/03906A patent/ZA201003906B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011509956A5 (https=) | ||
| JP2010001302A5 (https=) | ||
| JP2012501986A5 (https=) | ||
| JP2008526765A5 (https=) | ||
| CL2007002642A1 (es) | Compuestos derivados de 3-(6-oxo-1,6-dihidro-piridin-3-il)-benzamida; composicion farmaceutica; y uso en el tratamiento del cancer. | |
| CL2008001076A1 (es) | Compuestos derivados de sulfonamida; composicion farmaceutica; y uso en el tratamiento del cancer. | |
| JP2011515481A5 (https=) | ||
| JP2017505782A5 (https=) | ||
| JP2014530840A5 (https=) | ||
| CR20160131A (es) | Formulaciones de (s)-3-(4- ((4- (morfolinometil)benzil) oxi) -1-oxoisoindolin)-2-il) piperidin -2,6-diona | |
| JP2009536652A5 (https=) | ||
| CL2012000640A1 (es) | Uso del compuesto n-(4-((3-(2-amino-4-pirimidinil)-2-piridinil)oxi)fenil)-4-(4-metil-2-tienil)-1-ftalazinamina o su sal para el tratamiento de cancer refractario a tratamiento con un agente anti-cancer. | |
| JP2013507408A5 (https=) | ||
| JP2014509653A5 (https=) | ||
| JP2015507020A5 (https=) | ||
| JP2015527374A5 (https=) | ||
| JP2012067018A5 (https=) | ||
| JP2015516419A5 (https=) | ||
| CL2014001323A1 (es) | Compuestos derivados de 3-fenil-isoquinolin-1(2h)-ona, inhibidores de parp-1; procedimiento de preparacion; composicion farmaceutica; y uso en el tratamiento del cancer. | |
| JP2015506352A5 (https=) | ||
| IT1401284B1 (it) | Nuove formulazioni farmaceutiche idonee per la somministrazione orale di esomeprazolo magnesio diidrato, in forma di compresse mups (multi unit pellets system). | |
| JP2015503623A5 (https=) | ||
| JP2013507382A5 (https=) | ||
| JP2015500286A5 (https=) | ||
| BRPI0810682A2 (pt) | agente antitumoral em especial para o tratamento de tumores dérmicos, fármaco, kit compreendendo fármaco. |